Skip to main content
Steven Lentz, MD, Oncology, Iowa City, IA

StevenRLentzMD

Oncology Iowa City, IA

Professor, Internal Medicine, University of Iowa College of Medicine

Dr. Lentz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lentz's full profile

Already have an account?

  • Office

    200 Hawkins Dr
    Iowa City, IA 52242
    Phone+1 319-356-4048
    Fax+1 319-353-8383

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1988 - 1992
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1985 - 1988
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1985

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 1992 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Elected Member The American Society for Clinical Investigation, 2003

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Targeting Platelet EPCR for Better Therapeutic Factor VIIa Activity  
    Sean X Gu, Steven R Lentz, Journal of Thrombosis and Haemostasis

Abstracts/Posters

  • Targeting Metabolic Enzyme Pyruvate Kinase M2: A Novel Strategy to Inhibit Platelet Function and Arterial Thrombosis
    Steven R. Lentz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Consistency of Dosing of Turoctocog Alfa Pegol (N8-GP) throughout the Pathfinder Clinical Trials: Implications for Recommendations for Effective Prophylaxis, Bleed Res...
    Steven R. Lentz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Role of Low Albumin Levels in Pediatric Patients with Central Venous Catheters at Risk for Thrombosis
    Steven R. Lentz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Baltimore MD Confidential STD Testing – Hepatitis/Gonorrhea Fast Tests Launched
    Baltimore MD Confidential STD Testing – Hepatitis/Gonorrhea Fast Tests LaunchedOctober 4th, 2021
  • Phosphorylation of the Unique C-terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1α to Enhance Nerve Growth Factor Function
    Phosphorylation of the Unique C-terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1α to Enhance Nerve Growth Factor FunctionFebruary 27th, 2020
  • Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVR
    Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVRJuly 27th, 2016

Grant Support

  • Vascular Mechanisms In Homocysteinemia And AtherosclerosisNational Heart, Lung, And Blood Institute2009–2012
  • Structure And Function Of Cerebral Blood Vessels In HyperhomocysteinemiaNational Institute Of Neurological Disorders And Stroke2002–2012
  • Mouse PhenotypingNational Heart, Lung, And Blood Institute2011
  • Medical Scientist Training ProgramNational Institute Of General Medical Sciences2010–2011
  • Program In Hematology: Molecular &Cell Biology Blood CellsNational Heart, Lung, And Blood Institute2009–2011
  • Program In Hematology:&Cell Biology Blood CellsNational Heart, Lung, And Blood Institute2005–2007
  • Mechanisms Of Vascular Dysfunction In HomocysteinemiaNational Heart, Lung, And Blood Institute2000–2007

Professional Memberships